These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17965635)

  • 1. [Management of drug addiction in France (a short history)].
    Chossegros P
    Gastroenterol Clin Biol; 2007; 31(8-9 Pt 3):4S44-50. PubMed ID: 17965635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
    Varescon I; Vidal-Trécan G; Nabet N; Boissonnas A
    Encephale; 2002; 28(5 Pt 1):397-402. PubMed ID: 12386540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reduction in the number of lethal heroin overdoses in France since 1994. Focus on substitution treatments].
    Lepère B; Gourarier L; Sanchez M; Adda C; Peyret E; Nordmann F; Ben Soussen P; Gisselbrecht M; Lowenstein W
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS5-12. PubMed ID: 11435989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reimbursement of opiate substitution drugs to militaries in 2007].
    d'Argouges F; Desjeux G; Marsan P; Thevenin-Garron V
    Encephale; 2012 Sep; 38(4):304-9. PubMed ID: 22980471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dependence on psychotropic drugs and substitution treatment: recent trends. The OPPIDUM study of the Centers for Evaluation and Information on Drug Dependence (CEIP), October 1997].
    Thirion X; Micallef J; Guet F; Delarozière JC; Arditti J; Huntsman A; Sanmarco JL; Lagier G
    Therapie; 1999; 54(2):243-9. PubMed ID: 10394261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opiate addiction in China: current situation and treatments.
    Tang YL; Zhao D; Zhao C; Cubells JF
    Addiction; 2006 May; 101(5):657-65. PubMed ID: 16669899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Maintenance treatment with high-dose buprenorphine: are the recommendations being followed?].
    Seyer D; Dif C; Balthazard G; Sciortino V
    Therapie; 1998; 53(4):349-54. PubMed ID: 9806004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ambulatory medical treatment of drug dependent patients].
    Gölz J
    Z Arztl Fortbild (Jena); 1996 Jun; 90(4):271-8. PubMed ID: 8928526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Opiate replacement therapy in France: assessment of the public policies].
    Chast F
    Ann Pharm Fr; 2009 Sep; 67(5):299-303. PubMed ID: 19695365
    [No Abstract]   [Full Text] [Related]  

  • 10. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
    Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buprenorphine use: the international experience.
    Carrieri MP; Amass L; Lucas GM; Vlahov D; Wodak A; Woody GE
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S197-215. PubMed ID: 17109307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Role of pharmacy professionals in the network of drug addict care. Follow-up: buprenorphine, methadone, general practitioner network].
    Gelbhart P
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():67-8. PubMed ID: 7880027
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in high-dose buprenorphine maintenance therapy at the Fleury-Merogis (France) prison since 1996].
    Durand E
    Ann Med Interne (Paris); 2001 Nov; 152 Suppl 7():9-14. PubMed ID: 11965093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The profile of drug addicts attending the Sainte Marguerite University Hospital in Marseille analysis of the active file from 1996 to 2001].
    Lançon C; Jaquet I; Labrune N; Bartolo K; De Stopeleire C; Auquier P
    Presse Med; 2004 Oct; 33(18 Suppl):11-7. PubMed ID: 15617170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Opiate replacement therapy in France].
    Gatignol C
    Ann Pharm Fr; 2009 Sep; 67(5):360-4. PubMed ID: 19695372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine in primary care: risk factors for treatment injection and implications for clinical management.
    Roux P; Villes V; Blanche J; Bry D; Spire B; Feroni I; Carrieri MP
    Drug Alcohol Depend; 2008 Sep; 97(1-2):105-13. PubMed ID: 18479840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Opioid substitution therapy in France: a physician's overview].
    Michel L
    Ann Pharm Fr; 2009 Sep; 67(5):369-73. PubMed ID: 19695374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value and limitations of substitution treatments in the care of drug addicts].
    Carpentier J; Bloch-Lainé JF; Hefez S
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():50-1. PubMed ID: 7880019
    [No Abstract]   [Full Text] [Related]  

  • 20. [Psychotropic drug addiction: consumption study of specific population by the survey OPPIDUM 2004 from the CEIP network].
    Modelon H; Frauger E; Laurenceau D; Thirion X; Mallaret M; Micallef J;
    Therapie; 2007; 62(4):337-46. PubMed ID: 17983559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.